Skip to main content

Table 2 Study measures

From: A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: Is what they tell us important and true?

  (N = 20)  
  n (%)
1. Was the study valid?   
Yes 15 (75)
No 5 (25)
2. Was the study funded by a pharmaceutical company?   
Yes 16 (80)
No 1 (5)
Unknown 3 (15)
3. What was the study outcome?   
Patient-oriented 12 (60)
Disease-oriented 8 (40)
4. What was the study therapy compared to?   
Another medication or therapy 8 (40)
Placebo 10 (50)
Neither 2 (10)
5. Was a graphic* used on the brochure?   
Yes 19 (95)
No 1 (5)
6. Of the brochures with graphics, how was the data presented?   
Relative risk reduction 4 (21)
Absolute risk reduction 1 (5)
Other** 14 (74)
7. Was the outcome of interest statistically significant?***   
Yes 19 (95)
No 1 (5)
8. Did the data on the brochure differ from the underlying study?   
Yes 3 (15)
No 17 (85)
  1. *Includes bar charts, line graphs, pie charts, arrows
  2. **Includes mean change, point differences, etc
  3. ***p < 0.05